A detailed history of Morgan Stanley transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Morgan Stanley holds 361,189 shares of KOD stock, worth $2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
361,189
Previous 405,282 10.88%
Holding current value
$2 Million
Previous $952,000 1.05%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.2 - $3.25 $97,004 - $143,302
-44,093 Reduced 10.88%
361,189 $942,000
Q2 2024

Oct 17, 2024

SELL
$2.29 - $4.48 $1.15 Million - $2.26 Million
-503,569 Reduced 55.41%
405,282 $952,000
Q2 2024

Aug 14, 2024

SELL
$2.29 - $4.48 $1.15 Million - $2.26 Million
-503,569 Reduced 55.41%
405,282 $952,000
Q1 2024

Oct 17, 2024

BUY
$3.01 - $7.45 $1.52 Million - $3.75 Million
503,569 Added 124.25%
908,851 $4.78 Million
Q1 2024

Aug 16, 2024

BUY
$3.01 - $7.45 $2.04 Million - $5.05 Million
678,255 Added 294.13%
908,851 $4.78 Million
Q1 2024

May 15, 2024

BUY
$3.01 - $7.45 $2.04 Million - $5.05 Million
678,255 Added 294.13%
908,851 $4.78 Million
Q4 2023

Aug 16, 2024

SELL
$1.4 - $3.24 $244,560 - $565,982
-174,686 Reduced 43.1%
230,596 $701,000
Q4 2023

Feb 13, 2024

BUY
$1.4 - $3.24 $20,084 - $46,481
14,346 Added 6.63%
230,596 $701,000
Q3 2023

Nov 15, 2023

SELL
$1.8 - $7.49 $92,142 - $383,413
-51,190 Reduced 19.14%
216,250 $389,000
Q2 2023

Aug 14, 2023

SELL
$4.3 - $9.48 $1.18 Million - $2.6 Million
-273,856 Reduced 50.59%
267,440 $1.85 Million
Q1 2023

May 15, 2023

SELL
$4.81 - $8.88 $1.06 Million - $1.95 Million
-219,804 Reduced 28.88%
541,296 $3.36 Million
Q4 2022

Feb 14, 2023

SELL
$6.52 - $8.05 $801,425 - $989,489
-122,918 Reduced 13.9%
761,100 $5.45 Million
Q3 2022

Nov 14, 2022

SELL
$7.57 - $12.5 $500,649 - $826,700
-66,136 Reduced 6.96%
884,018 $6.84 Million
Q2 2022

Oct 27, 2022

SELL
$5.04 - $9.48 $2.09 Million - $3.93 Million
-414,179 Reduced 30.36%
950,154 $7.26 Million
Q2 2022

Aug 15, 2022

SELL
$5.04 - $9.48 $2.09 Million - $3.93 Million
-414,179 Reduced 30.36%
950,154 $7.26 Million
Q1 2022

Oct 27, 2022

BUY
$7.09 - $89.45 $2.94 Million - $37 Million
414,179 Added 43.59%
1,364,333 $10.5 Million
Q1 2022

May 13, 2022

BUY
$7.09 - $89.45 $7.88 Million - $99.4 Million
1,111,681 Added 440.0%
1,364,333 $10.5 Million
Q4 2021

Feb 14, 2022

SELL
$80.85 - $128.49 $498,116 - $791,626
-6,161 Reduced 2.38%
252,652 $21.4 Million
Q3 2021

Nov 15, 2021

BUY
$81.97 - $106.94 $21.2 Million - $27.7 Million
258,813 New
258,813 $24.8 Million

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $288M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.